Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation.

Asleh, Rabea; Briasoulis, Alexandros; Berinstein, Elliot M; Wiener, Joshua B; Palla, Mohan; Kushwaha, Sudhir S; Levy, Andrew P

Asleh, Rabea; Briasoulis, Alexandros; Berinstein, Elliot M; Wiener, Joshua B; Palla, Mohan; Kushwaha, Sudhir S; Levy, Andrew P.

Afiliação

Asleh R; Bruce and Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.
Briasoulis A; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Berinstein EM; Division of Cardiovascular Diseases, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Wiener JB; Bruce and Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.
Palla M; Bruce and Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.
Kushwaha SS; Department of Cardiology, Detroit Medical Center, Wayne State University, Detroit, MI, USA.
Levy AP; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.

Pharmgenomics Pers Med ; 11: 71-82, 2018.

Article em En | MEDLINE | ID: mdl-29731659

Palavras-chave

HDL dysfunction; antioxidants; cardiovascular disease; diabetes mellitus; haptoglobin genotype; vitamin E

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Pharmgenomics Pers Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Israel

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google